Visitors will need to show proof of vaccination and a negative COVID-19 test taken within three calendar days of travel
Court Temporarily Blocks Biden’s Vaccine Mandate for Big Businesses
Lawsuit questions whether the federal government exceeded its authority in issuing the rule
Unemployment Adversely Linked to Recommended Cancer Screening
Lower prevalence of screening for unemployed adults was no longer seen after accounting for health insurance coverage
Third BNT162b2 Vaccine Dose May Cut Severe COVID-19 Outcomes
Fewer hospital admissions, cases of severe disease, COVID-19-related deaths seen with third dose versus two doses received five months ago
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 1 to 5, 2021. This …
Pfizer Says New COVID-19 Pill Cuts Severe Disease by 89 Percent
Drug is designed to prevent the coronavirus from making copies of itself.
New U.S. COVID-19 Vaccinations Climb for the Longest Stretch in Months
However, at least some of the recent surge in first doses could also be from incorrectly reported booster shots
Insulin Rx Fills Down During the Pandemic
Findings significant for adults, but not pediatric subgroups
Heart Attack + COVID-19 Significantly Ups In-Hospital Mortality
Findings for both out-of-hospital and in-hospital ST-segment elevation myocardial infarction
Cervical Cancer Becoming Rare in the UK
After decades of research, the United Kingdom (UK) launched a human papillomavirus (HPV) vaccine program for teenage girls in 2008.
A new study published by The Lancet on November 3, 2021, shows the HPV vaccine dramatically reduces cervical cancer rates by almost 90% in women in their 20s who were offered the vaccine beginning at age 12.